Zydus Lifesciences (BOM:532321) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Zydus Lifesciences FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Zydus Lifesciences's Free Cash Flow for the three months ended in Dec. 2023 was ₹0 Mil. Zydus Lifesciences's Revenue for the three months ended in Dec. 2023 was ₹43,437 Mil. Therefore, Zydus Lifesciences's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Zydus Lifesciences's current FCF Yield % is 1.70%.

The historical rank and industry rank for Zydus Lifesciences's FCF Margin % or its related term are showing as below:

BOM:532321' s FCF Margin % Range Over the Past 10 Years
Min: -17.76 Med: 5.94 Max: 17.27
Current: 8.96

During the past 13 years, the highest FCF Margin % of Zydus Lifesciences was 17.27%. The lowest was -17.76%. And the median was 5.94%.

BOM:532321's FCF Margin % is ranked better than
75.46% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.55 vs BOM:532321: 8.96

Zydus Lifesciences FCF Margin % Historical Data

The historical data trend for Zydus Lifesciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zydus Lifesciences FCF Margin % Chart

Zydus Lifesciences Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

1.76

14.68

17.27

6.08

9.82

Zydus Lifesciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Zydus Lifesciences's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Zydus Lifesciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zydus Lifesciences's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zydus Lifesciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Zydus Lifesciences's FCF Margin % falls into.

Zydus Lifesciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Zydus Lifesciences's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	16579	/	168778
	=	9.82 %

Zydus Lifesciences's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	43437
	=	0.00 %

Zydus Lifesciences FCF Margin % Related Terms

Thank you for viewing the detailed overview of Zydus Lifesciences's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Zydus Lifesciences (BOM:532321) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zydus Lifesciences Ltd (BOM:532321) » Definitions » FCF Margin %

Traded in Other Exchanges

ZYDUSLIFE:India

Address

Scheme No. 63, Sarkhej-Gandhinagar Highway, Zydus Corporate Park, Survey No. 536, Near Vaishnodevi Circle, Khoraj (Gandhinagar), Ahmedabad, GJ, IND, 382481

Website

https://www.zyduslife.com

Zydus Lifesciences Ltd is a specialty and generic drug manufacturing company. The product portfolio of the group includes Active Pharmaceutical Ingredients, human formulations, Health and wellness, and Animal health and veterinary products. Its product brands include Aten, Falcigo, Nucoxia, Levoday, Metscore and Arzep among others. It has two segments Pharmaceuticals and Consumer Products. It generates majority of its revenue from the Pharmaceutical segment.

Zydus Lifesciences (BOM:532321) Headlines

No Headlines